BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24267593)

  • 1. Is parenteral phosphate replacement in the intensive care unit safe?
    Agarwal B; Walecka A; Shaw S; Davenport A
    Ther Apher Dial; 2014 Feb; 18(1):31-6. PubMed ID: 24267593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphate supplementation for hypophosphatemia during continuous renal replacement therapy in adults.
    Song YH; Seo EH; Yoo YS; Jo YI
    Ren Fail; 2019 Nov; 41(1):72-79. PubMed ID: 30909778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypophosphatemia on the intensive care unit: individualized phosphate replacement based on serum levels and distribution volume.
    Bech A; Blans M; Raaijmakers M; Mulkens C; Telting D; de Boer H
    J Crit Care; 2013 Oct; 28(5):838-43. PubMed ID: 23642477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of intravenous phosphate replacement in critically ill patients.
    Perreault MM; Ostrop NJ; Tierney MG
    Ann Pharmacother; 1997 Jun; 31(6):683-8. PubMed ID: 9184705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phoxilium vs Hemosol-B0 for continuous renal replacement therapy in acute kidney injury.
    Chua HR; Schneider AG; Baldwin I; Collins A; Ho L; Bellomo R
    J Crit Care; 2013 Oct; 28(5):884.e7-14. PubMed ID: 23683569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia.
    Charron T; Bernard F; Skrobik Y; Simoneau N; Gagnon N; Leblanc M
    Intensive Care Med; 2003 Aug; 29(8):1273-8. PubMed ID: 12845429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children.
    Santiago MJ; López-Herce J; Urbano J; Bellón JM; del Castillo J; Carrillo A
    Kidney Int; 2009 Feb; 75(3):312-6. PubMed ID: 19002217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid/base homeostasis.
    Ambühl PM; Meier D; Wolf B; Dydak U; Boesiger P; Binswanger U
    Am J Kidney Dis; 1999 Nov; 34(5):875-83. PubMed ID: 10561144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of a phosphate replacement strategy for severe hypophosphatemia in the ICU.
    Engwerda E; van den Berg M; Blans M; Bech A; de Boer H
    Neth J Med; 2018 Dec; 76(10):437-441. PubMed ID: 30569887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing Continuous Renal Replacement Therapy-Induced Hypophosphatemia: An Extended Clinical Experience with a Phosphate-Containing Solution in the Setting of Regional Citrate Anticoagulation.
    Pistolesi V; Zeppilli L; Polistena F; Sacco MI; Pierucci A; Tritapepe L; Regolisti G; Fiaccadori E; Morabito S
    Blood Purif; 2017; 44(1):8-15. PubMed ID: 28219057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical effects of phosphate-containing replacement fluid for continuous venovenous hemofiltration.
    Chua HR; Baldwin I; Ho L; Collins A; Allsep H; Bellomo R
    Blood Purif; 2012; 34(3-4):306-12. PubMed ID: 23235269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy.
    Troyanov S; Geadah D; Ghannoum M; Cardinal J; Leblanc M
    Intensive Care Med; 2004 Aug; 30(8):1662-5. PubMed ID: 15156308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refeeding syndrome: effective and safe treatment with Phosphates Polyfusor.
    Terlevich A; Hearing SD; Woltersdorf WW; Smyth C; Reid D; McCullagh E; Day A; Probert CS
    Aliment Pharmacol Ther; 2003 May; 17(10):1325-9. PubMed ID: 12755846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypophosphatemia: an evidence-based problem-solving approach to clinical cases.
    Assadi F
    Iran J Kidney Dis; 2010 Jul; 4(3):195-201. PubMed ID: 20622306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous phosphate repletion regimen for critically ill patients with moderate hypophosphatemia.
    Rosen GH; Boullata JI; O'Rangers EA; Enow NB; Shin B
    Crit Care Med; 1995 Jul; 23(7):1204-10. PubMed ID: 7600828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury.
    Demirjian S; Teo BW; Guzman JA; Heyka RJ; Paganini EP; Fissell WH; Schold JD; Schreiber MJ
    Nephrol Dial Transplant; 2011 Nov; 26(11):3508-14. PubMed ID: 21382993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hypophosphatemia after burn injury with a protocol for continuous, preemptive repletion.
    Kahn SA; Bell DE; Stassen NA; Lentz CW
    J Burn Care Res; 2015; 36(3):e220-5. PubMed ID: 25526178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Phosphate Containing Solutions with Incident Hypophosphatemia in Critically Ill Patients Requiring Continuous Renal Replacement Therapy.
    Thompson Bastin ML; Adams PM; Nerusu S; Morris PE; Mayer KP; Neyra JA
    Blood Purif; 2022; 51(2):122-129. PubMed ID: 33915554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypophosphatemia in parenteral nutrition: prevention and associated risks factors].
    Llop Talaverón JM; Comas Sugrañes D; Badía Tahull MB; Sáez Fernández A; Jódar Masanés R; Gómez Sáez JM
    Nutr Hosp; 2004; 19(6):362-6. PubMed ID: 15672652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of hypophosphatemia during continuous renal replacement therapy-An overlooked problem.
    Heung M; Mueller BA
    Semin Dial; 2018 May; 31(3):213-218. PubMed ID: 29405468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.